# Turkey Positioned as Strategic Growth Hub for Beckman Coulter EMEA

> Beckman Coulter Diagnostics highlights Turkey as a strategic high-volume growth market in its EMEA region, utilizing 40 years of local clinical expertise to enhance diagnostic automation across urban healthcare hubs.

Published: 2026-10-19T08:02:00+00:00
Language: en
Categories: [Laboratory and Test](https://chemexworld.com/en/categories/sectors/laboratory-and-test.md)

Canonical URL:
https://chemexworld.com/en/news/turkey-positioned-as-strategic-growth-hub-for-beckman-coulter-emea

## Content

With over 90 years of scientific and technological expertise in in-vitro diagnostics (IVD), Beckman Coulter Diagnostics operates across more than 130 countries with 11,000+ employees. Spanning core diagnostic disciplines—including clinical chemistry, immunoassay, hematology, microbiology, urinalysis, and blood banking—the company's automated architectures process more than one million patient samples every hour worldwide, supporting diagnostic decisions for over three million clinicians annually.

The structural modernization of Turkey's healthcare system—characterized by centralized public-private partnership (PPP) city hospital laboratories, university medical complexes, and private diagnostic chains—requires scalable laboratory automation capable of processing heavy sample flows under strict turnaround-time (TAT) and analytical accuracy constraints.

### High Test Volumes and Regional EMEA Benchmarking

Key operational and commercial highlights include:

- **Comprehensive Clinical Portfolio:** Deploying integrated track systems, automated sample handling, and algorithmic middleware to streamline clinical laboratories across hospital networks.
- **Five-Year Growth Trajectory:** The company recorded consistent commercial and operational expansion across Turkey over the past five years by integrating direct corporate engineering with domestic distribution infrastructures.
- **Regional Competency Hub:** Leveraging deep technical and clinical experience gained from managing high-volume domestic laboratories, Beckman Coulter Turkey is targeting an expanded role as a regional training and reference hub across the wider EMEA landscape.

### Executive Commentary from Berna Ünses

**Berna Ünses, General Manager of Beckman Coulter Diagnostics Turkey**, commented:

> We have maintained active operations in Turkey for over 40 years with the objective of improving laboratory throughput, safeguarding analytical precision, and empowering clinical decision-making. Domestic laboratories manage massive patient sample volumes within limited turnaround windows, making advanced digitization and total laboratory automation essential.
>
>
> Over the past five years, we achieved strong and consistent growth by combining our global technical foundation with the localized market access of our partner ecosystem. Our diagnostic platforms run across varied institutional tiers, from consolidated central networks to state-of-the-art city hospital complexes. The operational insights gathered from Turkey’s demanding clinical workloads deliver valuable input to our global R&D teams. We aim to leverage this localized operational excellence to elevate Turkey as a primary center of training and reference within the EMEA region.